(Abst.) Gilenya vs. Tecfidera in MS... on: June 08, 2018, 09:02:03 pm #1 From PubMed, June 8, 2018--"Fingolimod vs. dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study": Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study - PubMed This study provides Class IV evidence that for patients with RRMS, DMF and FNG have comparable efficacy in treatment-naive patients and that FNG is superior to DMF in patients switching from self-i... PubMed · ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
